Haemonetics Corp. buy BTIG Research
Start price
10.09.24
/
50%
€66.50
Target price
10.09.25
€101.52
Performance (%)
-32.03%
End price
11.09.25
€45.20
Summary
This prediction ended on 11.09.25 with a price of €45.20. Massive losses of -32.03% were the result for the BUY prediction by BTIG_Research. BTIG_Research has a follow-up prediction for Haemonetics Corp. where he still thinks Haemonetics Corp. is a Buy. BTIG_Research has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m | 1y |
|---|---|---|---|
| Haemonetics Corp. | 0.000% | 0.000% | - |
| iShares Core DAX® | 0.734% | 1.458% | 17.980% |
| iShares Nasdaq 100 | -2.686% | -0.146% | 3.810% |
| iShares Nikkei 225® | -2.261% | -2.729% | 11.679% |
| iShares S&P 500 | -1.346% | 0.467% | 1.970% |
Comments by BTIG_Research for this prediction
In the thread Haemonetics Corp. diskutieren
Haemonetics Co. (NYSE: HAE) is now covered by analysts at BTIG Research. They set a "buy" rating and a $112.00 price target on the stock.
Ratings data for HAE provided by MarketBeat
In the thread Trading Haemonetics Corp.
Die von BTIG_Research gewählte maximale Laufzeit wurde überschritten
Current prediction by BTIG_Research for Haemonetics Corp.
Haemonetics Corp.
Start price
Target price
Perf. (%)
€57.50
06.11.25
06.11.25
€76.46
06.11.26
06.11.26
25.22%
11.12.25
11.12.25
